Speech-Language Pathologists in Fairfield Township, OH Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Sydney Elizabeth Mills, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6711 Morris Rd, Fairfield Township, OH 45011 Phone: 513-737-5000 |
Lindsay Ruth Kluender Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6116 Morris Rd, Fairfield Township, OH 45011 Phone: 513-213-0994 |
Haley Mccarthy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6711 Morris Rd, Fairfield Township, OH 45011 Phone: 513-737-5000 |
Sarah-jane Marie Slater, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6711 Morris Rd, Fairfield Township, OH 45011 Phone: 513-737-5000 |
News Archive
The House approves six health-related measures, including legislation related to the disposal of unused prescription drugs
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy
The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.
BeiGene receives $5M from Merck to develop BGB-283 BRAF inhibitor
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
Fictional bird flu accounts point to need for emergency preparations - not panic
Highly publicized made for television dramas about fictional outbreaks of Asian Bird Flu highlight point to the need for preparation, not panic, Arizona state officials said.
› Verified 8 days ago
Speech-Language Pathologists
Chiropractors
Podiatrists
Optometrists
Occupational Therapists